FDAnews Drug Daily Bulletin

CENERX BIOPHARMA ANNOUNCES $18.5 MILLION SERIES A FINANCING

Dec. 2, 2005
A A

CeNeRx BioPharma, Inc., a start up bio-pharmaceutical company focused on developing new therapeutics for disorders of the central nervous system, today announced the completion of $18.5 million in series A financing. CeNeRx BioPharma (CeNeRx) is dedicated to acquiring and developing early-stage compounds for applications to treat central nervous system (CNS) disease. The company focuses on identifying promising therapeutics and moving the research forward to create medicines for the future.

American Venture Magazine (http://www.americanventuremagazine.com/news.php?newsid=582)